🏛️ Verified NIH Record • Updated 2025-05-19
Prospera Test Evaluation in Cardiac Transplant (ProTECT) (NCT05205551)
🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: Natera, Inc.
🩺 Plain-English Summary (8th-Grade Level)
The ProTECT registry is an observational longitudinal, multi-center study observing patients undergoing heart transplant for whom Prospera testing is part of routine clinical care, who are enrolled within 60 days of heart transplantation.
Who can join: Review the eligibility criteria below.
Location: Natera — San Carlos, California
Age range: 18 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Natera — San Carlos, California
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Heart Transplant Rejection
- Surveillance HeartCare® Outcomes Registry — Phoenix, Arizona
- Trifecta-Heart cfDNA-MMDx Study — Little Rock, Arkansas
- Mobile Video Directly Observed Therapy (DOT) for Immunosuppression Medication Adherence in Adolescent Heart Transplant Recipients — Coral Gables, Florida
Explore by condition: All Heart Transplant Rejection clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.